Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants-Reference-Cited by-同舟云学术

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

Published:2022-02-15 Issue:7 Volume:327 Page:639
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Accorsi Emma K.¹²,Britton Amadea¹²,Fleming-Dutra Katherine E.¹,Smith Zachary R.¹,Shang Nong¹,Derado Gordana¹,Miller Joseph¹,Schrag Stephanie J.¹,Verani Jennifer R.¹

Affiliation:

1. Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia

2. Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2788485/jama_accorsi_2022_oi_220006_1644783379.22837.pdf

Reference37 articles.

1. SARS-CoV-2 B.1.1.529 (Omicron) variant—United States, December 1-8, 2021.;CDC COVID-19 Response Team;MMWR Morb Mortal Wkly Rep,2021

2. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.;Wang;J Med Virol,2021

3. Community-based testing sites for SARS-CoV-2—United States, March 2020-November 2021.;Miller;MMWR Morb Mortal Wkly Rep,2021

4. Test-negative designs: differences and commonalities with other case-control studies with “other patient” controls.;Vandenbroucke;Epidemiology,2019

5. The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology.;Chua;Epidemiology,2020

Cited by 582 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling on COVID-19 control with double and booster-dose vaccination;Gene;2024-11

2. Comparison of Omicron and Delta Variants of SARS-CoV-2: A Systematic Review of Current Evidence;Infectious Disorders - Drug Targets;2024-11

3. Influenza virus strains expressing SARS-CoV-2 receptor binding domain protein confer immunity in K18-hACE2 mice;Vaccine: X;2024-10

4. Antibody responses post-booster COVID-19 vaccination: Insights from a single-center prospective cohort study;Diagnostic Microbiology and Infectious Disease;2024-10

5. Safety and antibody responses of Omicron BA.4/5 bivalent booster vaccine among hybrid immunity with diverse vaccination histories: A cohort study;Vaccine: X;2024-10